A106190 Stock Overview
Researches and develops, manufactures, and sells injectable carbapenem-based antibiotics worldwide.
Snowflake Score | |
---|---|
Valuation | 3/6 |
Future Growth | 0/6 |
Past Performance | 5/6 |
Financial Health | 5/6 |
Dividends | 1/6 |
Rewards
Risk Analysis
No risks detected for A106190 from our risk checks.
High Tech Pharm Co., Ltd. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | ₩13,920.00 |
52 Week High | ₩19,280.00 |
52 Week Low | ₩7,880.00 |
Beta | 0.91 |
11 Month Change | -21.62% |
3 Month Change | -2.04% |
1 Year Change | 33.76% |
33 Year Change | 18.64% |
5 Year Change | 80.78% |
Change since IPO | 51.30% |
Recent News & Updates
Is High Tech Pharm (KOSDAQ:106190) Using Too Much Debt?
Aug 06Subdued Growth No Barrier To High Tech Pharm Co., Ltd. (KOSDAQ:106190) With Shares Advancing 25%
Jul 02There's Reason For Concern Over High Tech Pharm Co., Ltd.'s (KOSDAQ:106190) Massive 25% Price Jump
May 09Recent updates
Is High Tech Pharm (KOSDAQ:106190) Using Too Much Debt?
Aug 06Subdued Growth No Barrier To High Tech Pharm Co., Ltd. (KOSDAQ:106190) With Shares Advancing 25%
Jul 02There's Reason For Concern Over High Tech Pharm Co., Ltd.'s (KOSDAQ:106190) Massive 25% Price Jump
May 09Is High Tech Pharm (KOSDAQ:106190) A Risky Investment?
Apr 23We Think High Tech Pharm (KOSDAQ:106190) Has A Fair Chunk Of Debt
Feb 23Did High Tech Pharm's (KOSDAQ:106190) Share Price Deserve to Gain 91%?
Jan 19What Is The Ownership Structure Like For High Tech Pharm Co., Ltd. (KOSDAQ:106190)?
Dec 15Shareholder Returns
A106190 | KR Pharmaceuticals | KR Market | |
---|---|---|---|
7D | -8.7% | -7.5% | -5.8% |
1Y | 33.8% | 5.7% | -4.3% |
Return vs Industry: A106190 exceeded the KR Pharmaceuticals industry which returned 5.7% over the past year.
Return vs Market: A106190 exceeded the KR Market which returned -4.3% over the past year.
Price Volatility
A106190 volatility | |
---|---|
A106190 Average Weekly Movement | 8.0% |
Pharmaceuticals Industry Average Movement | 6.7% |
Market Average Movement | 6.6% |
10% most volatile stocks in KR Market | 11.9% |
10% least volatile stocks in KR Market | 3.4% |
Stable Share Price: A106190's share price has been volatile over the past 3 months.
Volatility Over Time: A106190's weekly volatility (8%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1998 | n/a | Jeong-Soo Kim | www.htpharm.com |
High Tech Pharm Co., Ltd. researches and develops, manufactures, and sells injectable carbapenem-based antibiotics worldwide. The company was incorporated in 1998 and is based in Chungju-si, South Korea.
High Tech Pharm Co., Ltd. Fundamentals Summary
A106190 fundamental statistics | |
---|---|
Market cap | ₩148.01b |
Earnings (TTM) | ₩13.52b |
Revenue (TTM) | ₩83.50b |
10.9x
P/E Ratio1.8x
P/S RatioIs A106190 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
A106190 income statement (TTM) | |
---|---|
Revenue | ₩83.50b |
Cost of Revenue | ₩63.72b |
Gross Profit | ₩19.78b |
Other Expenses | ₩6.26b |
Earnings | ₩13.52b |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | 1.27k |
Gross Margin | 23.69% |
Net Profit Margin | 16.19% |
Debt/Equity Ratio | 14.9% |
How did A106190 perform over the long term?
See historical performance and comparison